CME Presentations

Narcolepsy


Presentations


Speakers


CME Information

Global Logo PQH Logo

Emerging Approaches and Patient‐centered Care for Narcolepsy

This activity is jointly provided by Global Education Group and PlatformQ Health Education, LLC, in collaboration with the American Sleep Association (ASA).

ACKNOWLEDGEMENT

This activity is supported by an educational grant from Avadel Pharmaceuticals.

LIVE DATE OF RELEASE

Monday, December 13, 2021, from 2:00 - 3:00pm ET.

TARGET AUDIENCE

The primary target audiences for the HCP activity are neurologists, sleep specialists, and specialty NPs and PAs. Secondary audiences include primary care physicians, internists, advanced practitioners, pharmacists, and nurses

STATEMENT OF NEED/PROGRAM OVERVIEW

Narcolepsy is a chronic neurologic disorder characterized by excessive daytime sleepiness (EDS), sleep paralysis, hypnagogic and hypnopompic hallucinations, disrupted nocturnal sleep, dysregulated rapid eye movement (REM) sleep, and cataplexy in most patients. Despite these obvious symptoms, narcolepsy is often under‐recognized, with diagnostic delays of up to 15 years, or misdiagnosed, depriving patients of appropriate treatment and care. However, if diagnosed accurately, emerging agents for narcolepsy could provide a new, patient‐centered management option.

Join a panel of expert clinicians and patient representatives for an in-depth discussion of the shifting standards of care for narcolepsy with or without cataplexy. Panelists will discuss strategies to address barriers to the recognition of the disorder and detail assessment tools and methods to ensure an accurate and timely diagnosis. In addition, the education will explore highly anticipated upcoming and more patient centered agents, indications, and classes of agents that are expected to further refine the narcolepsy treatment armamentarium.

Do you have patients who could benefit from related education on the recognition and care of narcolepsy? Direct your patients to MedLive.com to access the related patient-education activity, “More than Sleepiness: How Recognizing and Treating Narcolepsy Will Impact the Entire Family.”

EDUCATIONAL OBJECTIVES

After completing this activity, the participant should be better able to:
  • Describe signs and symptoms that support a suspicion of narcolepsy with/without cataplexy
  • Formulate a differential diagnosis for narcolepsy with/without cataplexy
  • Describe the adverse effects of EDS and interrupted sleep on patient QoL and overall health
  • Assess the safety, efficacy, and tolerability profiles of available and investigational therapies for the treatment of narcolepsy with/without cataplexy

PHYSICIAN ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PlatformQ Health Education, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN CREDIT DESIGNATION

Global Education Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ESTIMATED TIME TO COMPLETE

This activity should take approximately 60 minutes to complete.

INSTRUCTIONS TO RECEIVE CREDIT

In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FEE INFORMATION & REFUND/CANCELLATION POLICY

There is no fee for this educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

Name of Faculty or Presenter Reported Financial Relationship
Emmanuel Mignot, MD, PhD
Craig Reynolds Professor of Sleep Medicine
Stanford University
Consulting Fee: Centessa Pharmaceuticals, Eisai Pharmaceuticals , Inexia, Jazz Pharmaceuticals, Takeda Pharmaceuticals
Stock Shareholder: Centessa Pharmaceuticals
Other (Describe): Idorsia - coauthor helping to write a publication, but this does not involve any financial agreement.
Michael Thorpy, MD
Professor of Neurology
Albert Einstein College of Medicine
Consulting Fee: Axsome, Balance Therapeutics, Flamel/Avadel, Harmony Biosciences, LLC, Jazz Pharmaceuticals, Suven Life Sciences Ltd., Takeda Pharmaceutical Co., Ltd, NLS Pharmaceuticals and Eisai Pharmaceuticals

The planners and managers have the following relevant financial relationships with ineligible companies:

Name of Planner or Manager Reported Financial Relationship
Lindsay Borvansky Nothing to disclose
Andrea Funk Nothing to disclose
Liddy Knight Nothing to disclose
Ashley Cann Nothing to disclose
Kim Rodriguez Nothing to disclose
Carole Drexel Nothing to disclose
Eve Wilson Nothing to disclose
Caroline Laurendeau Nothing to disclose


DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PlatformQ Health Education, LLC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support:

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Technical Support:

For any technical issues or issues with your CME Certificate, please contact ClinicalSeriesLive at 877-394-1306 or at Support@ClinicalSeriesLive.com.

Mitigating Risk for Cardiovascular Disease in Narcolepsy


APCME LogoPQH Logo

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

  • Recognize disease pathophysiology and Identify factors that can play a significant role in the cardiovascular health of narcoleptic patients.
  • Appraise role wake promoting and anti-cataplectic medications for narcolepsy may play in affecting short-term as well and long-term cardiovascular health.
Organized by Atlanta Progressive CME in collaboration with PlatformQ Health Education, LLC

ACKNOWLEDGEMENT

This activity is supported by an independent educational grant from Jazz Pharmaceuticals.

TUITION

Complimentary

GOAL STATEMENT

This 60-minute CME activity features an expert faculty panel comprised of two sleep experts, a cardiologist and a dietitian, that will engage in an interactive discussion about current evidence-based insights to manage people with narcolepsy - cataplexy (type I) using a combination of medications and behavioral interventions to reduce the likelihood of stroke, myocardial infarction, heart failure and cardiac arrest in this vulnerable population. After examining the latest evidence and data surround emerging agents, the faculty will provide expert recommendations for the management of several patient scenarios, emphasizing strategies to address current gaps in the management of narcolepsy and discuss the place of novel, emerging agents in the treatment algorithm.

ACCREDITATION STATEMENT

Atlanta Progressive CME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Internet Live Course

Atlanta Progressive CME designates this internet live course for a maximum of 1 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

Atlanta Progressive CME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Atlanta Progressive CME will issue non-physician health professionals a certificate of participation that references AMA PRA Category 1 Credits ™, to help them document their participation in certified educational activities.

DATE OF RELEASE/EXPIRATION

Live Activity

June 17, 2020 from 12:00-1:00pm ET.

Enduring Material

The enduring material will be available from June 17, 2020 – June 17, 2021.

TARGET AUDIENCE

This activity was developed for sleep specialists, neurologists, psychiatrists, primary care physicians, advanced practice nurses, and physician assistants.

ESTIMATED TIME TO COMPLETE

This activity consists of 1 session which should take approximately 1 hour to complete.

METHOD OF PARTICIPATION

There are no fees to participate in this activity. To participate in the activity, go to www.NeuroSeriesLive.com or www.ClinicalSeriesLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

DISCLOSURE OF CONFLICTS OF INTEREST

It is the policy of Atlanta Progressive CME to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. In accordance with the Accreditation Council for Continuing Medical Education’s (ACCME’s) Standards for Commercial Support, all persons in the position to control the CME content are required to disclose to the accredited provider their relevant financial relationships. An individual has a relevant financial relationship if he or she (or spouse/partner) has a financial relationship in any amount occurring in the last 12 months that create a conflict of interest. The ACCME considers financial relationships to create conflicts of interest in CME when individuals have both a financial relationship with a commercial interest and the opportunity to affect the content of CME about the products or services of that commercial interest. ACCME defines a commercial interest, as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Faculty or Presenter Reported Financial Relationship
Russell Rosenberg, PhD, Planner and Presenter
CEO, Atlanta Progressive CME and Atlanta School of Sleep Medicine & Technology, Atlanta, Georgia
Russell Rosenberg, PhD, has disclosed no relevant financial relationships.
Lee A. Surkin, MD, FACC, FCCP, FASNC
ABIM, Board Certified in Cardiovascular Disease and Sleep Medicine
Board Certified in Nuclear Cardiology
President, Empire Sleep Medicine
Founder, American Academy of Cardiovascular Sleep Medicine
Lee Surkin, MD, has disclosed the following relevant financial relationships: Serves as a consultant for VirtuOX, Inc., and serves on the advisory board for Jazz Pharmaceuticals.
Michael Thorpy, MD, Presenter
Professor of Clinical Neurology at Albert Einstein College of Medicine and Director of the Sleep-Wake Disorders Center at the Montefiore Medical Center, Bronx, New York
Michael Thorpy, MD, has disclosed the following relevant financial relationships: Served as a consultant for and received a clinical research grant from Jazz Pharmaceuticals, Flamel/Avadel, Axsome Therapeutics, Balance Therapeutics, Takeda, and Suven Life Sciences.
Margot Witteveen, MS, RDN, LD, Presenter
Co-founder, Perfectly Portioned Wellness
Atlanta, GA
Margot Witteveen, MS, RDN, LD, has disclosed no relevant financial relationships.

The planners and reviewers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Faculty or Presenter Reported Financial Relationship
Heidi Riney, MD, Independent Content Reviewer
Medical Director, Fusion Sleep, Atlanta, Georgia
Heidi Riney, MD, has disclosed no relevant financial relationships.

The following PlatformQ Health Education, LLC planner, Elizabeth del Nido, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

PROGRAM ORIGIN

This CME activity was developed in collaboration with PlatformQ Health Education (https://platformqhealth.com/).
This CME activity is licensed to Atlanta Progressive CME. Copyright © 2020
No part of this activity may be reproduced without written permission from Atlanta Progressive CME.

CONTACT INFORMATION

Accreditation Support:
Please contact Atlanta Progressive CME at http://www.atlantaprogressivecme.com/.

Technical Support:
For any technical issues or issues with your CME Certificate, please contact NeuroSeriesLive or ClinicalSeriesLive at 877-394-1306 or at Support@NeuroSeriesLive.com.